Loading clinical trials...
Loading clinical trials...
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Conditions
Interventions
IVT aflibercept
Sham SC
+1 more
Locations
29
United States
Retinal Consultants of Arizona and Retinal Research Institute
Phoenix, Arizona, United States
Retina Centers, PC
Tucson, Arizona, United States
California Retina Consultants
Bakersfield, California, United States
Retina Vitreous Medical Group Clinical Research
Beverly Hills, California, United States
Northern California Retina Vitreous Associates Medical Group, Inc.
Mountain View, California, United States
Retina Institute of California
Palm Desert, California, United States
Start Date
July 11, 2017
Primary Completion Date
April 17, 2018
Completion Date
April 17, 2018
Last Updated
May 13, 2021
NCT07425522
NCT07308639
NCT07449936
NCT07449923
NCT06439576
NCT07228559
Lead Sponsor
Clearside Biomedical, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions